[Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement]
- PMID: 14694554
[Follow up after an abnormal pap smear: time interval acceptable, nature of follow up leaves room for improvement]
Abstract
Objective: To investigate whether the interval between an abnormal Pap smear and follow-up is too long and whether the guidelines for histological follow-up after an abnormal Pap smear are being followed.
Design: Descriptive.
Method: Data on all Pap smears of a minimum Pap class 3a (moderate dysplasia) from the national cervical-cancer screening programme in the Rotterdam area of the Netherlands were acquired from the Pathological Anatomical National Automated Archive (PALGA). The test results from each woman were arranged chronologically and the nature of the follow-up cervical examinations (cytological and histological) was recorded. The observation period was 360 days. The average interval in days between Pap smear and follow-up as well as the nature of the follow-up were analysed.
Results: In total, data on 156 women were analysed. In 93% of women follow-up was done during our observation period. The average interval was 60 days. In 80% of the women follow-up took place within 3 months and in 90% within 6 months. In 32% of women in the follow-up group the Pap smear was repeated at their first follow-up visit and in the remaining cases, a histological examination was performed according to the guidelines. In 7% of cases no cytological or histological follow-up at all took place within the year.
Conclusion: The average interval between an abnormal Pap smear and follow-up is acceptable because of the slow natural course of cervical carcinoma. Attention should be focused on the incorrect repetition of the cytological test and on the fact that in a number of cases no follow-up at all is done within 1 year.
Similar articles
-
[Follow-up not according to guidelines after an abnormal cervix smear].Ned Tijdschr Geneeskd. 1996 Apr 13;140(15):833-6. Ned Tijdschr Geneeskd. 1996. PMID: 8668277 Dutch.
-
[Less pap-2 results ('minor abnormalities') in the population screening for cervical cancer since the introduction of new guidelines in 1996].Ned Tijdschr Geneeskd. 2002 Aug 24;146(34):1586-90. Ned Tijdschr Geneeskd. 2002. PMID: 12224483 Dutch.
-
Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):204-9. doi: 10.1016/j.ejogrb.2007.10.017. Epub 2008 Feb 21. Eur J Obstet Gynecol Reprod Biol. 2008. PMID: 18093720
-
[The Pap test revisited].Minerva Ginecol. 1991 Mar;43(3):71-85. Minerva Ginecol. 1991. PMID: 2057106 Review. Italian.
-
[Population screening for uterine cervix cancer: the negative effects of insufficient knowledge as to what is normal and abnormal].Ned Tijdschr Geneeskd. 2002 Aug 24;146(34):1569-71. Ned Tijdschr Geneeskd. 2002. PMID: 12224477 Review. Dutch.
Cited by
-
Clinical Significance of Atypical Squamous and Glandular Cell Lesions in Cervical Smear Screening Cytology: A Two-Year Follow-Up Study in an Iranian Population.Iran J Pathol. 2024 Fall;19(4):376-383. doi: 10.30699/IJP.2024.2020412.3242. Epub 2024 Oct 29. Iran J Pathol. 2024. PMID: 40034929 Free PMC article.
-
National Policies to Prevent and Manage Cervical Cancer in East African Countries: A Policy Mapping Analysis.Cancers (Basel). 2020 Jun 10;12(6):1520. doi: 10.3390/cancers12061520. Cancers (Basel). 2020. PMID: 32531977 Free PMC article.